Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 3, 2006, Pages 563-570

  Bateman, Eric D ^a   Jacques, Loretta ^b   Goldfrad, Caroline ^b   Atienza, Tito ^c   Mihaescu, Triaian ^d   Duggan, Marie ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Veterans Memorial Medical Centre   (Philippines)

^d GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Asthma; Control; Fluticasone propionate; Fluticasone propionate salmeterol; Maintenance; Step down

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DRUG DOSE REGIMEN; EXPIRATORY FLOW RATE; FEMALE; HOARSENESS; HUMAN; INHALER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; THRUSH;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PEAK EXPIRATORY FLOW RATE;

EID: 33644763830     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.11.036     Document Type: Article

References (16)

1. Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention. NHLBI/WHO workshop report 2002 National Institutes of Health, National Heart, Lung and Blood Institute Bethesda (MD) NIH publication #02-3659
2. 2-agonists and inhaled corticosteroids: a paradigm shift in asthma management Pharmacotherapy 22 2002 212 226
3. E.D. Bateman, J. Bousquet, and G.L. Braunstein Is overall asthma control being achieved? a hypothesis-generating study Eur Respir J 17 2001 589 595
4. E. Bateman, H. Boushey, J. Bousquet, W. Busse, T. Clark, and R. Pauwels Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma controL study Am J Respir Crit Care Med 170 2004 836 844
5. H.K. Reddel, C.R. Jenkins, G.B. Marks, S.I. Ware, W. Xuan, and C.M. Salome Optimal asthma control, starting with high doses of inhaled budesonide Eur Respir J 16 2000 226 235
6. G. Hawkins, A. McMahon, S. Twaddle, S. Wood, I. Ford, and N. Thomson Stepping down inhaled corticosteroids in asthma: randomised controlled trial BMJ 326 2003 1115 1120
7. CPMP/EWP/482/99. Points to consider on switching between superiority and non-inferiority 1999 European Agency for the Evaluation of Medicinal Products London
8. E.D. Bateman, V. Silins, and M. Bogolubov Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100mcg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild to moderate asthma Respir Med 95 2001 136 146
9. J.A. Van Noord, H. Hill, C. Diaz, A.P. Greefhorst, and P. Davies Clinical equivalence of a salmeterol/fluticasone propionate combination product (50/500mcg) delivered via a chlorofluorocarbon-free metered dose inhaler with the DISKUS in patients with moderate to severe asthma Clin Drug Invest 21 2001 243 255
10. E.D. Bateman, L.J. Frith, and G.L. Braunstein Achieving guideline-based asthma control: does the patient benefit? Eur Respir J 20 2002 588 595
11. R.A. Nathan, C.A. Sorkness, M. Kosinski, M. Schatz, J.T. Li, and P. Marcus Development of the asthma control test: a survey for assessing asthma control J Allergy Clin Immunol 113 2004 59 65
12. K.F. Rabe, P.A. Vermeire, J.B. Soriano, and W.C. Maier Clinical management of asthma in 1999; the Asthma Insights and Reality in Europe (AIRE) study Eur Respir J 16 2000 802 807
13. K.F. Rabe, M. Adachi, C.K.W. Lai, J.B. Soriano, P.A. Vermeire, and K.B. Weiss Worldwide severity and control of asthma in children and adults: the global Asthma Insights and Reality surveys J Allergy Clin Immunol 114 2004 40 47
14. C. Ward, M. Pais, R. Bish, D. Reid, B. Feltis, and D. Johns Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma Thorax 57 2002 309 316
15. J.K. Sont, L.N.A. Willems, E.H. Bel, H.J.M. van Kriekan, J.P. Vandenbrouchke, P.J. Sterk the AMPUL study group Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment Am J Respir Crit Care Med 159 1999 1043 1051
16. H.K. Reddel Goals of asthma treatment: how high should we go? Eur Respir J 24 2004 715 717